Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats-Reference-Cited by-同舟云学术

Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats

Published:1996-05 Issue:4 Volume:82 Page:361-368
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Katsuura Yasuhiro,Okamoto Shosuke,Ohno Norio,Wanaka Keiko

Publisher

Elsevier BV

Subject

Hematology

Reference30 articles.

1. Humoral mediators of MOF;Fry;Arch Surg,1986

2. Clinical analysis of multiple organ failure in burned patients;Aikawa;Burns,1987

3. Determinants of death in patients with intraabdominal abscess;Fry;Surgery,1980

4. The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease;Mason;Thromb Diathes Haemorragh,1971

5. Plasma prekallikrein, factor XII, antithrombin III, Ci-inhibitor and α2-macroglobulin in critically III patients with suspected disseminated intravascular coagulation (DIC);Lämmle;Am J Clin Pathol,1984

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Kallikrein Inhibitors in Cardiovascular Disease;Cardiology in Review;2016-05

2. Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis;Thrombosis Research;2012-10

3. Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats;European Journal of Pharmacology;2003-02

4. Development of plasma kallikrein selective inhibitors;Biopolymers;1999

5. The Coagulation Pathway and Antithrombotic Strategies;Antithrombotics;1999